The Centers for Disease Control and Prevention estimates that there are 2.9 million individuals in the U.S. infected with chronic hepatitis C (HCV). The landscape of HCV treatment has shifted rapidly in the past few years with the introduction of oral, curative direct-acting antiviral (DAA) treatment. This session will provide a practice update on HCV and the unique role that occupational health nurses can play in worksite screening, coaching employees who test positive, and benefits design related to drug coverage.
Identify which persons should be screened for hepatitis C.
Summarize the role of occupational health nurses in screening and linkage patients to care.
Describe and restate what treatments are available for hepatitis C.